{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:33:59Z","timestamp":1790508839281,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":660,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.diagmicrobio.2011.05.007","type":"journal-article","created":{"date-parts":[[2011,8,16]],"date-time":"2011-08-16T23:04:22Z","timestamp":1313535862000},"page":"126-130","source":"Crossref","is-referenced-by-count":25,"title":["In vitro synergisms obtained by amphotericin B and voriconazole associated with non-antifungal agents against Fusarium spp"],"prefix":"10.1016","volume":"71","author":[{"given":"Tarcieli P.","family":"Venturini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Rossato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana B.","family":"Spader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giordano R.","family":"Tronco-Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Izabel","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline B.","family":"Weiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janio M.","family":"Santurio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney Hartz","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0005","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1182\/blood.V90.3.999","article-title":"Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management","volume":"90","author":"Boutati","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0010","first-page":"1848","author":"Brunton","year":"2007"},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0015","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1128\/AAC.41.4.850","article-title":"In vitro activity of fluvastatin, a cholesterol-lowering agent, and synergy with fluconazole and itraconazole against Candida species and Cryptococcus neoformans","volume":"41","author":"Chin","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jac\/41.1.127","article-title":"The combination of amphotericin B and azithromycin as a potential new therapeutic approach to fusariosis: in vitro demonstration of synergy","volume":"41","author":"Clancy","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0025","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1128\/AAC.42.3.509","article-title":"Inhibition of RNA synthesis as a therapeutic strategy against Aspergillus and Fusarium: demonstration of in vitro synergy between rifabutin and amphotericin B","volume":"42","author":"Clancy","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0030","series-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2008"},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijantimicag.2007.09.005","article-title":"In vitro interactions of antifungal agents against clinical isolates of Fusarium spp","volume":"31","author":"C\u00f3rdoba","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0040","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/jac\/dkh434","article-title":"Combinations of antifungal agents in therapy \u2014 what value are they?","volume":"54","author":"Cuenca-Estrella","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0045","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1439-0507.1997.tb00212.x","article-title":"Interactions between amphotericin B and nitroimidazoles against Candida albicans","volume":"40","author":"Cury","year":"1997","journal-title":"Mycoses"},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0050","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/AAC.17.3.484","article-title":"Combined effect of amphotericin B and rifampin on Candida species","volume":"17","author":"Edwards","year":"1980","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0055","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1128\/AAC.19.1.196","article-title":"Combined in vitro effect of amphotericin B and rifampin on Cryptococcus neoformans","volume":"19","author":"Fujita","year":"1981","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0060","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1128\/AAC.43.5.1256","article-title":"In vitro and in vivo experimental activities of antifungal agents against Fusarium solani","volume":"43","author":"Guarro","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0065","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1128\/AAC.25.5.560","article-title":"In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp","volume":"25","author":"Hughes","year":"1984","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0070","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1128\/AAC.9.6.908","article-title":"Antimicrobial susceptibility testing of six clinical isolates of Aspergillus","volume":"9","author":"Kitahara","year":"1976","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/AAC.5.1.16","article-title":"Effects of rifamycin derivatives, alone and in combination with amphotericin B, against Histoplasma capsulatum","volume":"5","author":"Kobayashi","year":"1974","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0080","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/clinids\/22.Supplement_1.S3","article-title":"Antimicrobial activity of rifabutin","volume":"22","author":"Kunin","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0085","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/clinids\/5.Supplement_3.S614","article-title":"Antifungal activity of rifampin","volume":"5","author":"Medoff","year":"1983","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0090","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/CMR.18.1.163-194.2005","article-title":"Combination treatment of invasive fungal infections","volume":"18","author":"Mukherjee","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0095","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1099\/0022-1317-51-2-105","article-title":"Effect of fluvastatin and pravastatin, HMG-CoA reductase inhibitors, on fluconazole activity against Candida albicans","volume":"51","author":"Nash","year":"2002","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.diagmicrobio.2007.10.015","article-title":"Fluvastatin potentiates the activity of caspofungin against Aspergillus fumigatus in vitro","volume":"60","author":"Natesan","year":"2008","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0105","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/342328","article-title":"Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management","volume":"35","author":"Nucci","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0110","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00014-07","article-title":"Fusarium infections in immunocompromised patients","volume":"20","author":"Nucci","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0115","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1086\/383319","article-title":"Fusarium infection in hematopoietic stem cell transplant recipients","volume":"38","author":"Nucci","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0120","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1128\/JCM.00533-07","article-title":"Phylogenetic diversity and microsphere array-based genotyping of human pathogenic fusaria, including isolates from the multistate contact lens-associated U.S. keratitis outbreaks of 2005 and 2006","volume":"45","author":"O'donnell","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0125","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1099\/0022-1317-49-9-831","article-title":"Antifungal activity of ibuprofen alone and in combination with fluconazole against Candida species","volume":"49","author":"Pina-Vaz","year":"2000","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/jac\/39.2.163","article-title":"In vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains","volume":"39","author":"Pujol","year":"1997","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0135","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1086\/503425","article-title":"Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions","volume":"42","author":"Raad","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0140","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1128\/AAC.39.12.2610","article-title":"Demonstration of synergy with fluconazole and either ibuprofen, sodium salicylate, or propylparaben against Candida albicans in vitro","volume":"39","author":"Scott","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0145","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1439-0507.2009.01773.x","article-title":"In vitro interactions between amphotericin B and other antifungal agents and rifampin against Fusarium spp","volume":"54","author":"Spader","year":"2009","journal-title":"Mycoses"},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0150","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1128\/AAC.00735-07","article-title":"Isobolographic analysis of pharmacodynamic interactions between antifungal agents and ciprofloxacin against Candida albicans and Aspergillus fumigatus","volume":"52","author":"Stergiopoulou","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2011.05.007_bb0155","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0002-9394(78)90240-4","article-title":"In vitro antibiotic synergism against ocular fungal isolates","volume":"86","author":"Stern","year":"1978","journal-title":"Am. J. Ophthalmol."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889311001842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889311001842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T09:50:36Z","timestamp":1592819436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889311001842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0732889311001842"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2011.05.007","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}